DEPLOY

Buying guide

Happy Ring vs Withings ScanWatch in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

  • Withings ScanWatch has more verified real-world deployments (1 vs 0).
Attribute
ManufacturerHappy HealthWithings
Form factorbiometricbiometric
Maturitycommercialcommercial
Autonomy
Availabilityinternal-onlyenterpriseshipping-nowshipping
PriceNot announced$349-$600 (actual sale price)
Capability claims
Brain
Verified deployments01Withings
Privacy practices4biometric-storage, data-sale, data-deletion-control, data-retention
Sources on file710

Editorial summaries

Happy Ring

The Happy Ring (from Happy Health Inc, Austin, Texas; CEO Dustin Freckleton, MD) is the FDA-cleared, service-gated archetype of the ring sub-cohort, and the sharpest verified-vs-claimed counterpoint to RingConn: the same finger-ring form factor and similar sleep-apnea capability claims, but a diametrically opposite verification posture. Its cleared sleep-apnea algorithm is the regulatory substance, with two dated FDA 510(k) clearances: K240236 (October 8, 2024) for retrospective remote monitoring of physiological parameters in adults at home or in healthcare facilities; and K242224 (June 18, 2025) for a Home Sleep Test that processes the ring's signals for clinician-interpreted diagnosis of sleep disorders such as obstructive sleep apnea and insomnia, ages 22+, under the direction of a trained healthcare provider (clinician-directed, not autonomous diagnosis). It is not a standalone retail ring: it is sold only bundled into the clinician-reviewed, insurer-billed 'Happy Sleep' home-sleep-test service, so there is no published consumer price. Cap-flags: a 97% agreement with polysomnography is company-reported with no peer-reviewed citation; the 'brain biometrics' marketing is not substantiated by any named EEG hardware; and funding is a $60M Series A (August 2022, ARCH Venture Partners) with no later round surfaced, an early-stage state.

Withings ScanWatch

The Withings ScanWatch (the ScanWatch 2 at about $349 and the ScanWatch Nova, including the Nova Brilliant at about $600, November 2024; from Withings, founded 2008 in France and independent since buying itself back from Nokia in 2018) is the hybrid-analog entry of the biometric cohort: a conventional analog watch dial paired with medical sensors (optical PPG, electrical ECG, SpO2, and TempTech24/7 continuous temperature) and about 30-day battery. Its cleared features include ECG (for AFib, sinus rhythm, and high heart rate, cleared 2021, with an OTC ECG clearance in 2025), SpO2 with breathing-disturbance detection, and temperature trends, with an optional Withings+ subscription (~$9.95/month). It carries substantial peer-reviewed cardiologist validation for the size of the company. Cap-flag: as a French maker it is cleared in both the EU and the US, with different specific indications by region.

Common questions

What is the difference between Happy Ring and Withings ScanWatch?
Happy Ring and Withings ScanWatch are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which has more verified deployments, Happy Ring or Withings ScanWatch?
Withings ScanWatch has more verified deployments (1) on the DEPLOY registry than Happy Ring (0). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Related comparisons

Keep researching

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.


Machine-readable: this page as markdown.

← Back to all consumer robots